Yat-Sun Or
SrVP and CSO at Enanta Pharmaceuticals
📍 Watertown, Massachusetts, United States
Yat-Sun Or is the Senior Vice President and Chief Scientific Officer at Enanta Pharmaceuticals, where he has directed drug discovery since 1999. He is a prolific inventor with over 260 filed U. S. patent applications and holds a Ph. D. in Organic Chemistry from the University of Chicago.
He is the co-inventor of Enantas commercially successful protease inhibitors, glecaprevir (MAVYRET®) and paritaprevir (VIEKIRA PAK®), for the treatment of chronic hepatitis C virus.
Read the full overview →Current Role
SrVP and CSO
Location
Watertown, Massachusetts, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Yat-Sun cares about
Antiviral Drug Discovery
Leads scientific research for virology and immunology at Enanta and is a co-inventor on numerous patents for antiviral compounds targeting HCV, RSV, and other viruses.
Hepatitis C Therapeutics
Played a pivotal role in inventing glecaprevir and paritaprevir, two commercially successful drugs that have significantly impacted Hepatitis C (HCV) treatment.
Career
Work history
SrVP and CSO
Enanta Pharmaceuticals
CSO
Enanta Pharmaceuticals
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
Yat-Sun has no verified education history
Social presence
Other Enanta Pharmaceuticals Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.